文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

比利时CRB1相关视网膜营养不良队列的遗传特征与长期临床随访

CRB1-associated retinal dystrophies in a Belgian cohort: genetic characteristics and long-term clinical follow-up.
PubMed 文献 · Br J Ophthalmol · 2021-02-12

双等位CRB1突变导致以早期黄斑受累为特征的一组进行性视网膜疾病,多数为全视网膜受累,RP和LCA分别在第四个和第一个十年之前存在基因治疗干预窗口。

要点

  • 70%患者达到视力盲(<0.05),68%(17/25)达到视野盲(<10°)。
  • 黄斑受累见于所有患者,RP中囊样黄斑病变占43%(9/21),MD中占100%(3/3)。

核心结论

  • 双等位CRB1突变导致一组进行性视网膜疾病,多数为全视网膜受累,以早期黄斑受累为特征。
  • 视觉功能与视网膜结构分析提示RP在第四个十年之前、LCA在第一个十年之前存在基因治疗潜在干预窗口。

研究设计与样本

  • 随访超过1年的患者占63%,平均随访12.0年(范围2.3-29.2年)。

主要发现

  • 22例(55%)诊断为视网膜色素变性(RP),15例(38%)为Leber先天性黑矇(LCA),3例(8%)为黄斑营养不良(MD)。
  • MD与p.(Ile167_Gly169del)突变复合杂合相关,其中1例MD later发展为视杆-视锥营养不良。
  • LCA在生命第一个十年、RP在第五个十年出现初诊时盲。
  • 最终28例(70%)达到视力盲(<0.05),17/25例(68%)记录到视野盲(<10°)。
  • 5例(13%)发生Coats样渗出性血管病变,3例(8%)发现中间/后葡萄膜炎。

关键数值与推荐

  • 视力盲定义为最佳矫正视力<0.05,视野盲定义为视野<10°。
  • 囊样黄斑病变在RP中占43%(9/21),在MD中占100%(3/3)。
  • 黄斑受累表现为从视网膜色素上皮改变到完全外视网膜萎缩,见于所有患者。

临床怎么用

  • 对CRB1相关视网膜营养不良患者应早期评估黄斑结构,因其普遍存在黄斑受累。
  • RP患者建议在第四个十年之前、LCA患者在第一个十年之前评估基因治疗干预可能性。
  • 随访中需关注Coats样渗出性血管病变和葡萄膜炎等并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To investigate the natural history in a Belgian cohort of CRB1-associated retinal dystrophies. METHODS: An in-depth retrospective study focusing on visual function and retinal structure. RESULTS: Forty patients from 35 families were included (ages: 2.5-80.1 years). In patients with a follow-up of >1 year (63%), the mean follow-up time was 12.0 years (range: 2.3-29.2 years). Based on the patient history, symptoms and/or electroretinography, 22 patients (55%) were diagnosed with retinitis pigmentosa (RP), 15 (38%) with Leber congenital amaurosis (LCA) and 3 (8%) with macular dystrophy (MD), the latter being associated with the p.(Ile167_Gly169del) mutation (in compound heterozygosity). MD later developed into a rod-cone dystrophy in one patient. Blindness at initial presentation was seen in the first decade of life in LCA, and in the fifth decade of life in RP. Eventually, 28 patients (70%) reached visual acuity-based blindness (<0.05). Visual field-based blindness (<10°) was documented in 17/25 patients (68%). Five patients (13%) developed Coats-like exudative vasculopathy. Intermediate/posterior uveitis was found in three patients (8%). Cystoid maculopathy was common in RP (9/21; 43%) and MD (3/3; 100%). Macular involvement, varying from retinal pigment epithelium alterations to complete outer retinal atrophy, was observed in all patients. CONCLUSION: Bi-allelic CRB1 mutations result in a range of progressive retinal disorders, most of which are generalised, with characteristically early macular involvement. Visual function and retinal structure analysis indicates a window for potential intervention with gene therapy before the fourth decade of life in RP and the first decade in LCA.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Talib M, Van Cauwenbergh C, De Zaeytijd J, et al. CRB1-associated retinal dystrophies in a Belgian cohort: genetic characteristics and long-term clinical follow-up. Br J Ophthalmol. 2021. PMID: 33579689. doi:10.1136/bjophthalmol-2020-316781

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。